查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835519

医药物流市场按类型、组成部分、产品、运输方​​式、应用和最终用户划分－2025-2032 年全球预测

Pharmaceutical Logistics Market by Type, Component, Product, Mode Of Transport, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医药物流市场规模将成长至 1,120.6 亿美元，复合年增长率为 5.48%。

主要市场统计数据
基准年2024年 731.2亿美元
预计2025年 768.6亿美元
预测年份：2032年 1120.6亿美元
复合年增长率（%） 5.48%

权威的医药物流导向阐明了塑造弹性供应链的营运压力、合规要求和投资重点

医药物流领域面临临床紧迫性、监管严格性和全球贸易复杂性等多重挑战。近年来，医药供应链经受突发中断、温度控制要求不断变化以及监管机构和付款方日益严格的审查的考验。因此，物流相关人员平衡这些相互竞争的挑战：一方面要透过不折不扣的产品完整性来确保病患安全，另一方面要在有限的营运环境中优化成本和前置作业时间。

本报告全面分析了影响物流供应商、製造商和医疗保健买家的营运现状、技术应用趋势和政策动态。报告重点分析了物流网络中的关键弱点和优势，并强调了合作伙伴关係在维持连续性方面的作用。透过评估基础设施能力、服务设计和合规义务之间的相互关係，领导者可以确定投资的优先顺序，以降低风险并提高应对力。

整个审查重点关注新兴实践的实际意义，例如先进的温度监测、端到端可视化平台以及模组化仓储策略。这些要素不仅考虑其技术复杂性，还考虑其营运可行性、实施成本以及与临床、商业和监管职能部门相关人员期望的一致性。

技术进步、产品复杂性的提高以及策略整合正在迅速将医药物流转变为可靠的、数据主导的服务经济

受技术日趋成熟、产品配置不断变化以及监管要求不断提高的推动，医药物流格局正在经历重大变革。复杂的生技药品和个人化疗法推动了对整个配送生命週期内精确温控和持续追踪的需求，加速了低温运输专业化和先进监控解决方案的采用。同时，支援即时视觉和预测分析的数位平台正在将价值获取从单纯的产能转向服务品质和可靠性。

同时，该产业正在经历第三方物流供应商的整合，以及运输公司与生命科学公司之间的策略联盟，重塑了网路设计和服务交付。这些结构性变化正透过对灵活储存和包装系统的投资而得到强化，这些系统支援多品种、小批量生产以及快速履约时效性交付。此外，出于环境永续性考虑，可重复使用包装和节能冷藏仓库的试验正在推进，这为营运商的决策标准增添了新的维度。

综上所述，这些发展趋势要求企业重新定位自身能力。整合强大的监控、灵活的储存和敏捷的运输编配的供应商能够满足不断变化的产品复杂性和不断增长的客户期望。同时，製造商和机构投资者正在重新评估其供应商选择标准，强调可靠性、数据透明度和成熟的低温运输专业知识，从而为物流采购创造新的竞争格局。

2025年美国关税措施对全球供应链药品路线、供应商选择和贸易合规策略的实际影响

2025年美国关税环境将对医药物流决策造成复杂影响，重塑全球供应链的路线、采购和成本分配。不断变化的关税政策迫使相关人员重新评估其供应商和承运商的选择，以降低到岸成本波动并保持供应的连续性。对于许多生命科学公司而言，其立即采取的应对措施是战术性的，例如重新规划货运路线以避开高关税通道、增加对保税仓库的依赖，以及在可行的情况下加快本地化进程，以减少对关税敏感型物流的敞口。

除了这些直接调整之外，关税情势也促使企业进行策略转变。企业正在重新设计其区域网络，以实现跨港口和运输方式的入境流量多元化，并与物流合作伙伴重新协商商业条款，以共用或对冲关税风险。此外，企业更加重视文件完整性和海关合规能力，以最大程度地减少可能加剧关税财务影响的昂贵延误和罚款。这些变化也对库存管理产生了间接影响，一些企业选择增加附近物流中心的安全库存，以抵消潜在的边境干扰。

关税主导的重组凸显了敏捷性和情境规划在物流策略中的重要性。那些主动将贸易政策敏感性纳入其路线演算法、供应商合约和库存定位的企业，将在维持服务水准的同时，在不确定的贸易环境中管理成本风险方面占据优势。

可操作的细分情报，区分低温运输和非低温运输需求、组件功能、产品复杂性、运输方式、应用领域和最终用户期望

详细分析细分市场，可以揭示指南策略投资的差异化需求和服务期望。就物流类型而言，低温运输物流要求端到端温度的完整性、严格的隔热包装合格以及支援监管可追溯性的监控技术；而非低温运输物流则强调大批量处理、高效的运输和成本优化的仓储策略。在这些类型之间转换需要清晰的营运流程和资本配置决策。

组件级细分进一步明确了能力差距和采购优先顺序：包装解决方案必须平衡热性能和材料永续性，而储存和仓储需要设施合格、检验的温度区域以及训练有素的人员来管理敏感库存。

产品主导的细分支援服务差异化。单株抗体、胜肽和蛋白质等生技药品通常需要严格的低温运输管理和可追溯处理，而品牌药通常将温度要求与商业分销规则结合。学名药分为非处方药和处方仿製学名药，每种药的需求模式和包装弹性各不相同，这会影响运输频率、容器化和库存策略的选择。

运输方式的细分会影响速度、成本和风险状况。空运，无论是包机或商用，都优先考虑速度并尽量减少停留时间。道路运输与铁路和卡车运输相结合，可提供经济高效的跨区域运输和最后一英里的灵活配送。

基于应用的细分突出了特定行业的工作流程：生物製药需要严格的合规通讯协定，并且通常需要低温运输专业知识；化学製药需要危险品专业知识和受控环境；特种製药可能结合了独特的处理、安全和文件需求。最后，最终用户细分（医疗保健提供者、製药商和研究机构）决定了服务等级协议、交付流程以及附加价值服务，例如直接送达诊所和实验室检测套组管理。

从区域观点探讨美洲、欧洲、中东、非洲和亚太地区医药物流的基础设施、监管细节和营运重点

区域动态正在影响物流供应商和製药公司的营运重点和投资决策。在美洲，重点关注规模化和最后一英里的优化，特别关注北美的跨境物流以及拉丁美洲市场的基础设施差异。这需要製定灵活的运输策略、提升通关效率，并建立能够在不同地区提供一致低温运输服务的伙伴关係。

欧洲、中东和非洲地区部分地区法规统一，其他地区基础设施分散，导致合规性和营运要求参差不齐。供应商必须在利用先进枢纽能力的集中配送模式与本地化解决方案之间取得平衡，以应对最后一英里的复杂性和特定国家的法规。该地区也为节能冷藏仓库解决方案和整合式视觉化平台提供了发展机会，有助于管理跨境低温运输的完整性。

亚太地区持续呈现製造业快速扩张、都市化带来的最后一公里挑战以及普遍的基础设施成熟等特征。生技药品产能的不断扩大以及该地区许多市场对先进低温运输能力的需求，正在推动对合格仓储和多式联运方案的投资。区域相关人员越来越重视将本地市场专业知识与全球标准相结合的伙伴关係关係，以管理合规性、安全性和服务可靠性。

决定医药分销物流供应商和技术/供应商成功的关键竞争优势和伙伴关係策略

物流和服务供应商之间的竞争动态正集中体现在几个关键的差异化因素：成熟的低温运输专业知识、数位化视觉性和分析能力、合规性和品管，以及与细分市场专业化相结合的地理覆盖范围。领先的供应商正在投资于检验的仓储设施、整合监控系统以及支援温敏生生技药品和大宗药品分销的服务组合。在此过程中，他们正在将自身定位从单纯的运输企业转变为提供端到端责任制的综合供应链合作伙伴。

策略伙伴关係和收购正被用于加速能力建设，尤其是在需要专业低温运输服务或快速进入新兴市场的情况下。提供监控硬体和软体平台的技术供应商正越来越多地与物流供应商合作，将持续温度感测、自动警报和数据分析融入其日常营运中。这种整合增强了合规性文檔，减少了手动流程，并支援基于绩效的商业模式。

从买家的角度来看，供应商的选择标准正在发生变化，更注重透明度、事件回应能力和审核流程。企业也在评估供应商在不损害低温运输完整性的情况下，支持循环包装倡议和永续性承诺的能力。因此，那些能够在服务可靠性、强大的品质系统和清晰的创新蓝图取得显着改进的供应商最有可能赢得策略合约。

为产业领导者提供实用、多方面的蓝图，以加强低温运输弹性、贸易敏捷性和策略伙伴关係，同时推动营运课责

产业领导者必须制定综合性议程，在短期韧性与长期转型之间取得平衡。首先，投资分级低温运输基础设施，将设施合格和温控技术与产品风险状况相符。这种方法能够有效地将高成本资源分配给对温度最敏感的SKU，同时保持灵活性，以满足更广泛的配送需求。与实体投资相辅相成的是采用先进的监控和分析技术，从被动事件管理转向预测性维护和路线最佳化。

其次，我们将贸易政策和海关专业知识融入供应链规划，以缓解关税和监管波动的影响。基于情境的建模和动态路由通讯协定降低了我们受突发政策变化影响的风险，而加强与承运商的合约条款使我们能够在高风险区域共用风险。第三，我们优先与专业供应商和技术供应商建立合作关係，以加速产能扩张。策略合作伙伴关係可以提供有效的冷资料储存、最后一哩专业知识和整合数据平台，而无需我们完全自行开发。

最后，创建一个协调采购、品质和营运的管治和绩效架构。实施清晰的服务等级协定、事件回应程序和持续改善週期，可以确保责任制，并推动可衡量的可靠性改进。透过实施这种多层面的策略，领导者可以降低服务中断的风险，实际管理成本，并增强其支援日益复杂的药品组合的能力。

透明的、以从业者为中心的调查方法将主要的领导访谈与辅助的二手资讯相结合，以提供可行的物流见解

本分析整合了主要研究和二手资料，旨在对医药物流动态进行严谨且可复製的评估。主要研究包括对来自製造和医疗保健公司的高级物流主管、低温运输专家、法规合规官以及采购专业人员的结构化访谈。这些访谈重点在于营运重点、能力差距、技术采用以及对贸易和政策变化的回应，从而提供一线观点，并最终提出切实可行的建议。

二次研究涵盖公开的监管指南、产业白皮书、技术提供者规格以及关键物流实施案例。我们将主要见解与二次证据进行三角检验，从而检验了新兴主题，包括对生技药品低温运输日益增长的关注、数位化视觉化的重要性以及关税变动对营运的影响。透过对受访者进行交叉检验、对通用模式进行迭代合成，以及关注影响可行性和优先排序的区域差异因素，我们保持了调查方法的严谨性。

我们的分析着重于结构性和业务趋势，而非量化的市场规模。我们的分析涵盖广泛的地区和相关人员，但微观市场的细微差别可能需要区域检验。我们的调查方法注重适用性，确保我们的研究结果能够支援采购、营运和策略规划的可行决策。

关于低温运输能力、数位视觉性和管治的策略投资为何决定医药供应链领导地位的总结性观点

高效率的医药物流不再只是后勤部门职能，而是竞争优势。随着产品复杂性和监管要求的提高，其重要性只会与日俱增。将物流视为战略能力、投资高效的低温运输基础设施、整合先进的监控和分析技术，并在计划中融入贸易政策适应力的组织，将更有能力确保产品完整性、满足患者需求并控制药品供应的总成本。

此外，技术与专业服务模式的整合创造了将供应商关係从交易型转变为策略型伙伴关係的机会。透过优先考虑透明度、数据主导的决策和持续改进，相关人员可以减少供应中断并提高营运灵活性。随着各行各业适应波动的关税、不断变化的产品配置和区域基础设施差异，将洞察力转化为敏捷执行的能力将使领导者与落后者脱颖而出。

这意味着要根据产品风险进行相应的投资，利用伙伴关係关係来加速能力提升，并将管治制度化，将营运改善转化为可靠、审核的绩效，从而实现永续、有弹性的医药物流，维护患者安全和商业连续性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 采用区块链通讯协定实现医药供应链端到端可追溯性
  • 整合物联网温度感测器和自动警报系统，确保低温运输完整性
  • 引入人工智慧预测分析，用于医学流的需求预测和库存优化
  • 物流供应商和监管机构将共同努力，加强整个全部区域的合规性和风险管理。
  • 引入绿色包装解决方案，减少药品分销网络中的碳排放
  • 利用自动送货车辆和无人机在偏远医疗市场进行最后一英里的配送
  • 开发数位双胞胎平台，即时模拟和优化医药供应链运营
  • 扩大多式联运网络，利用海陆空一体化运输方式运输温度敏感型药品

第六章 2025年美国关税的累积影响

第七章 人工智慧的累积影响，2025年

第八章：按类型分類的医药物流市场

  • 低温运输物流
  • 非低温运输物流

9. 医药物流市场（依组成部分）

  • 分配
  • 监控
  • 包装
  • 储存/仓储

第 10 章：按产品分類的医药物流市场

  • 生技药品
    • 单株抗体
    • 胜肽
    • 蛋白质
  • 品牌药
  • 学名药
    • 非处方药
    • 学名药

第十一章 医药物流市场依运输方式划分

  • 空运
    • 包机服务
    • 商业货物
  • 道路运输
    • 铁路
    • 卡车运输
  • 海运
    • 货柜运输
    • 滚装/滚卸

第十二章医药物流市场应用

  • 生物製药
  • 化学品和製药
  • 特种製药

第 13 章：医药物流市场（依最终使用者）

  • 医疗保健提供者
  • 製药製造业
  • 研究所

第十四章医药物流市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章医药物流市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章：各国医药物流市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • AP Moller-Maersk A/S
    • Air Canada
    • AIT Worldwide Logistics, Inc.
    • Almac Group
    • AWL India Private Limited
    • Bilcare Limited
    • CH Robinson Worldwide, Inc.
    • Catalent, Inc.
    • Cencora Inc.
    • CEVA Logistics
    • Clinigen Group PLC
    • Crown LSP Group
    • DHL International GmbH by Deutsche Post AG
    • DSV A/S
    • FedEx Corporation
    • ICON PLC
    • Infosys Limited
    • Kerry Logistics Network Limited
    • Kuehne+Nagel International AG
    • Lineage, Inc.
    • Lonza Group Ltd.
    • Movianto Group
    • NextPharma Logistics GmbH
    • Nippon Express Co., Ltd.
    • Parexel International Corporation
    • SEKO Logistics
    • SF Express Co., Ltd.
    • Thermo Fisher Scientific, Inc.
    • United Parcel Service of America, Inc.
    • YUSEN LOGISTICS CO., LTD.
Product Code: MRR-437E8FA7421A

The Pharmaceutical Logistics Market is projected to grow by USD 112.06 billion at a CAGR of 5.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 73.12 billion
Estimated Year [2025] USD 76.86 billion
Forecast Year [2032] USD 112.06 billion
CAGR (%) 5.48%

An authoritative orientation to pharmaceutical logistics that clarifies operational pressures, compliance imperatives, and investment priorities shaping resilient supply chains

The pharmaceutical logistics sector operates at the confluence of clinical urgency, regulatory rigor, and global trade complexity. In recent years, supply chains for pharmaceuticals have been tested by episodic disruptions, evolving temperature-control demands, and heightened scrutiny from regulators and payors. Consequently, logistics stakeholders must balance competing imperatives: ensuring patient safety through uncompromising product integrity while simultaneously optimizing cost and lead times in a constrained operating environment.

This report presents an integrated vantage that synthesizes operational realities, technology adoption trends, and policy dynamics affecting logistics providers, manufacturers, and institutional buyers. It frames critical vulnerabilities and strengths within distribution networks and underscores the role of collaborative partnerships in maintaining continuity. By assessing the interplay between infrastructure capabilities, service design, and compliance obligations, the analysis helps leaders prioritize investments that reduce risk and increase responsiveness.

Throughout the review, emphasis is placed on the practical implications of emerging practices such as advanced temperature monitoring, end-to-end visibility platforms, and modular warehousing strategies. These elements are examined not only for their technological sophistication but also for their operational feasibility, cost-to-implement considerations, and alignment with stakeholder expectations across clinical, commercial, and regulatory functions.

How technological advances, product complexity, and strategic consolidation are rapidly reshaping pharmaceutical logistics into a reliability- and data-driven service economy

The landscape of pharmaceutical logistics is undergoing transformative shifts driven by technological maturation, changing product profiles, and intensified regulatory expectations. Complex biologic products and personalized therapies have increased demand for precise temperature controls and serialized tracking throughout the distribution lifecycle, which in turn accelerates adoption of cold chain specialization and advanced monitoring solutions. Simultaneously, digital platforms enabling real-time visibility and predictive analytics are shifting value capture from capacity alone toward service quality and reliability.

In parallel, the industry is witnessing consolidation among third-party logistics providers and strategic alliances between carriers and life sciences companies, which reconfigure network design and service offerings. These structural changes are reinforced by investments in flexible storage and packaging systems that support multi-temperature SKUs and rapid fulfillment for time-sensitive deliveries. Moreover, environmental sustainability considerations are prompting experimentation with reusable packaging and energy-efficient cold storage, adding another layer of decision criteria for operators.

Taken together, these developments demand a reorientation of capabilities. Providers that integrate robust monitoring, adaptable storage, and agile transport orchestration position themselves to meet evolving product complexity and heightened customer expectations. At the same time, manufacturers and institutional buyers are recalibrating supplier selection criteria to emphasize reliability, data transparency, and proven cold chain expertise, creating a new competitive dynamic in logistics procurement.

Practical implications of the 2025 United States tariff policy on pharmaceutical routing, supplier selection, and trade-compliance strategies across global supply chains

The United States tariff environment in 2025 has created a complex overlay on pharmaceutical logistics decisions, reshaping routing, sourcing, and cost allocation across global supply chains. Tariff policy changes have prompted stakeholders to reassess supplier and carrier selection in order to mitigate landed-cost volatility and maintain supply continuity. For many life sciences organizations, the immediate response has been tactical: rerouting shipments to avoid high-duty corridors, increasing reliance on bonded warehousing, and accelerating localization where feasible to reduce exposure to tariff-sensitive flows.

Beyond those immediate adjustments, the tariff landscape is also catalyzing strategic shifts. Firms are reassessing regional network design to diversify inbound flows across ports and transport modes, and are renegotiating commercial terms with logistics partners to share or hedge tariff risk. In addition, companies are placing greater emphasis on documentation integrity and customs compliance capabilities to minimize costly delays and penalties that can compound the financial impact of duties. These changes have secondary effects on inventory policy, with some organizations opting to increase safety stock in proximate distribution centers to offset potential border disruptions.

Ultimately, the tariff-driven reconfiguration highlights the importance of agility and scenario planning in logistics strategy. Organizations that proactively incorporate trade-policy sensitivity into routing algorithms, supplier contracts, and inventory positioning will be better equipped to preserve service levels while managing cost exposure in an uncertain trade environment.

Actionable segmentation intelligence that differentiates cold chain and non-cold chain needs, component capabilities, product complexity, transport modes, application niches, and end-user expectations

A granular view of segmentation reveals differentiated needs and service expectations that should guide strategic investments. When considering logistical type, cold chain logistics demands end-to-end temperature integrity, rigorous qualification of insulated packaging, and monitoring technologies that support regulatory traceability, whereas non-cold chain logistics emphasizes volume handling, transit efficiency, and cost-optimized storage strategies. Transitioning between these types requires distinct operational protocols and capital allocation decisions.

Component-level segmentation further clarifies capability gaps and procurement priorities. Distribution operations call for flexible transportation modes and reliable carrier networks; monitoring necessitates investment in sensors, data platforms, and analytics to evidence compliance; packaging solutions must balance thermal performance with material sustainability; and storage and warehousing require facility qualification, validated temperature zones, and trained personnel to manage sensitive inventory.

Product-driven segmentation underpins service differentiation. Biologic products, including monoclonal antibodies, peptides, and proteins, typically require stringent cold chain controls and traceable handling, while branded drugs often combine temperature requirements with commercial distribution rules. Generic pharmaceuticals split into over-the-counter and prescription generics, each presenting different demand patterns and packaging resilience, which influence choices in transport frequency, containerization, and inventory tactics.

Mode of transport segmentation influences speed, cost, and risk profiles. Air freight, whether via charter services or commercial cargo, prioritizes speed and minimal dwell time; road transportation-across rail and trucking-offers cost-efficient regional connectivity and flexibility for last-mile delivery; and sea freight through container shipping or roll-on/roll-off presents economies for bulk international movements but introduces longer lead times and greater exposure to temperature excursions.

Application-based segmentation highlights sector-specific workflows. Bio pharma requires stringent compliance protocols and often cold chain specialization, chemical pharma demands hazardous-material handling expertise and controlled environments, and specialized pharma may combine unique handling, security, and documentation needs. Finally, end-user segmentation into healthcare providers, pharmaceutical manufacturing, and research institutions shapes service level agreements, delivery cadence, and value-added services such as direct-to-clinic fulfillment or clinical trial kit management.

A region-by-region perspective on infrastructure, regulatory nuance, and operational priorities shaping pharmaceutical logistics in the Americas, EMEA, and Asia-Pacific

Regional dynamics shape operational priorities and investment decisions for logistics providers and pharmaceutical companies. In the Americas, emphasis is placed on distribution scale and last-mile optimization, with particular attention to cross-border flows in North America and to infrastructure variability across Latin American markets. These conditions require adaptable transport strategies, enhanced customs proficiency, and partnerships that can deliver consistent cold chain performance across diverse geographies.

In Europe, Middle East & Africa, regulatory harmonization in parts of Europe intersects with fragmented infrastructure in other areas, creating a mosaic of compliance and operational requirements. Providers must balance centralized distribution models that leverage advanced hub capabilities with localized solutions that handle last-mile complexity and country-specific regulations. The region also presents opportunities to deploy energy-efficient cold storage solutions and integrated visibility platforms to manage cross-border cold chain integrity.

Asia-Pacific continues to be characterized by rapidly evolving manufacturing footprints, urbanization-driven last-mile challenges, and a broad spectrum of infrastructure maturity. Many markets within the region are scaling up biologics manufacturing capacity and demand sophisticated cold chain capabilities, prompting investments in qualified warehousing and multimodal transport options. Across regions, stakeholders increasingly prioritize partnerships that combine local market expertise with global standards to manage compliance, security, and service reliability.

Key competitive differentiators and partnership strategies that are defining success among logistics providers and technology suppliers in pharmaceutical distribution

Competitive dynamics among logistics and service providers are converging on a few decisive differentiators: proven cold chain expertise, digital visibility and analytics, compliance and quality management, and geographic reach combined with niche specialization. Leading providers are investing in validated storage facilities, integrated monitoring systems, and service portfolios that support temperature-sensitive biologics alongside high-volume pharmaceutical distribution. In doing so, they are repositioning from pure-transport businesses toward integrated supply chain partners that offer end-to-end accountability.

Strategic partnerships and acquisitions are being used to accelerate capability development, especially where rapid entry into specialized cold chain services or regional markets is required. Technology vendors that supply monitoring hardware and software platforms are increasingly collaborating with logistics providers to embed continuous temperature sensing, automated alerts, and data analytics into routine operations. This integration enhances compliance documentation, reduces manual processes, and supports performance-based commercial models.

From a buyer perspective, supplier selection criteria have shifted to emphasize transparency, incident response capability, and auditable processes. Organizations are also evaluating providers on their ability to support circular packaging initiatives and sustainability commitments without compromising cold chain integrity. As a result, providers that can demonstrate measurable improvements in service reliability, robust quality systems, and a clear roadmap for innovation are most likely to capture strategic engagements.

A pragmatic, multi-dimensional roadmap for industry leaders to strengthen cold chain resilience, trade agility, and strategic partnerships while driving operational accountability

Industry leaders must adopt an integrated agenda that balances immediate resilience with longer-term transformation. First, invest in tiered cold chain infrastructure that aligns facility qualification and temperature-control technology to product risk profiles. This approach enables efficient allocation of high-cost resources to the most temperature-sensitive SKUs while preserving flexibility for broader distribution needs. Complementary to physical investments, deploy advanced monitoring and analytics to move from reactive incident management toward predictive maintenance and route optimization.

Second, embed trade-policy and customs expertise into supply chain planning to mitigate tariff and regulatory volatility. Scenario-based modeling and dynamic routing protocols can reduce exposure to sudden policy shifts, while stronger contractual terms with carriers can share risk in high-exposure corridors. Third, prioritize partnerships with specialized providers and technology vendors to accelerate capability expansion; strategic alliances can deliver validated cold storage, last-mile expertise, and integrated data platforms without requiring full in-house development.

Finally, build governance and performance frameworks that align procurement, quality, and operations. Instituting clear service-level agreements, incident response playbooks, and continuous improvement cycles ensures accountability and drives measurable reliability gains. By pursuing this multi-pronged strategy, leaders can reduce service disruption risk, control costs pragmatically, and strengthen their ability to support increasingly complex pharmaceutical product portfolios.

A transparent, practitioner-focused research methodology integrating primary leadership interviews and corroborating secondary sources to produce actionable logistics insights

This analysis synthesizes primary and secondary research to produce a rigorous, reproducible assessment of pharmaceutical logistics dynamics. Primary research included structured interviews with senior logistics executives, cold chain specialists, regulatory compliance leads, and procurement professionals across manufacturing and healthcare organizations. These conversations focused on operational priorities, capability gaps, technology adoption, and responses to trade and policy shifts, providing frontline perspectives that inform practical recommendations.

Secondary research comprised a review of publicly available regulatory guidance, industry white papers, technology provider specification documents, and case studies from leading logistics implementations. Triangulation of primary insights with secondary evidence allowed for validation of emergent themes such as the increased focus on biologics cold chain, the centrality of digital visibility, and the operational consequences of tariff shifts. Methodological rigor was maintained through cross-validation among interviewees, iterative synthesis of common patterns, and attention to regional differentiators that affect feasibility and prioritization.

Limitations are acknowledged: the analysis focuses on structural and operational trends rather than quantitative market sizing, and while it accounts for a broad set of geographies and stakeholder types, some micro-market nuances may require localized validation. Nonetheless, the methodology emphasizes applicability, ensuring that findings support actionable decisions for procurement, operations, and strategic planning.

Concluding perspective on why strategic investment in cold chain capabilities, digital visibility, and governance will determine pharmaceutical supply chain leadership

Effective pharmaceutical logistics is now a competitive enabler rather than a back-office function, and its importance will only increase as product complexity and regulatory expectations rise. Organizations that treat logistics as a strategic capability-investing in validated cold chain infrastructure, integrating advanced monitoring and analytics, and embedding trade-policy resilience into planning-will be better positioned to ensure product integrity, meet patient needs, and manage total cost to serve.

Moreover, the convergence of technology and specialized service models creates an opportunity to shift provider relationships from transactional to strategic partnerships. By prioritizing transparency, data-driven decision-making, and continuous improvement, stakeholders can reduce supply disruptions and create operational agility. As the industry adapts to tariff dynamics, evolving product profiles, and regional infrastructure variances, the capacity to translate insight into nimble execution will distinguish leaders from laggards.

In closing, the imperative is clear: align investments to product risk, leverage partnerships to accelerate capability, and institutionalize governance that converts operational improvements into reliable, auditable performance. Doing so will enable sustainable, resilient pharmaceutical logistics that uphold patient safety and commercial continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of blockchain protocols for end-to-end traceability in pharmaceutical supply chains
  • 5.2. Integration of IoT temperature sensors with automated alert systems for cold chain integrity
  • 5.3. Deployment of AI predictive analytics for demand forecasting and inventory optimization in pharma logistics
  • 5.4. Collaboration between logistics providers and regulatory bodies to enhance compliance and risk management across regions
  • 5.5. Implementation of green packaging solutions to reduce carbon footprint in pharmaceutical distribution networks
  • 5.6. Use of autonomous delivery vehicles and drones for last mile distribution in remote healthcare markets
  • 5.7. Development of digital twin platforms to simulate and optimize pharmaceutical supply chain operations in real time
  • 5.8. Expansion of multi-modal transport networks leveraging air, sea, and ground integration for temperature-sensitive drugs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Logistics Market, by Type

  • 8.1. Cold Chain Logistics
  • 8.2. Non-Cold Chain Logistics

9. Pharmaceutical Logistics Market, by Component

  • 9.1. Distribution
  • 9.2. Monitoring
  • 9.3. Packaging
  • 9.4. Storage & Warehousing

10. Pharmaceutical Logistics Market, by Product

  • 10.1. Biologic Products
    • 10.1.1. Monoclonal Antibodies
    • 10.1.2. Peptides
    • 10.1.3. Proteins
  • 10.2. Branded Drugs
  • 10.3. Generic Pharmaceuticals
    • 10.3.1. Over-The-Counter (OTC)
    • 10.3.2. Prescription Generics

11. Pharmaceutical Logistics Market, by Mode Of Transport

  • 11.1. Air Freight
    • 11.1.1. Charter Services
    • 11.1.2. Commercial Cargo
  • 11.2. Road Transportation
    • 11.2.1. Rail
    • 11.2.2. Trucking
  • 11.3. Sea Freight
    • 11.3.1. Container Shipping
    • 11.3.2. Roll-On/Roll-Off

12. Pharmaceutical Logistics Market, by Application

  • 12.1. Bio Pharma
  • 12.2. Chemical Pharma
  • 12.3. Specialized Pharma

13. Pharmaceutical Logistics Market, by End User

  • 13.1. Healthcare Providers
  • 13.2. Pharmaceutical Manufacturing
  • 13.3. Research Institutions

14. Pharmaceutical Logistics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pharmaceutical Logistics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pharmaceutical Logistics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. A.P. Moller - Maersk A/S
    • 17.3.2. Air Canada
    • 17.3.3. AIT Worldwide Logistics, Inc.
    • 17.3.4. Almac Group
    • 17.3.5. AWL India Private Limited
    • 17.3.6. Bilcare Limited
    • 17.3.7. C.H. Robinson Worldwide, Inc.
    • 17.3.8. Catalent, Inc.
    • 17.3.9. Cencora Inc.
    • 17.3.10. CEVA Logistics
    • 17.3.11. Clinigen Group PLC
    • 17.3.12. Crown LSP Group
    • 17.3.13. DHL International GmbH by Deutsche Post AG
    • 17.3.14. DSV A/S
    • 17.3.15. FedEx Corporation
    • 17.3.16. ICON PLC
    • 17.3.17. Infosys Limited
    • 17.3.18. Kerry Logistics Network Limited
    • 17.3.19. Kuehne + Nagel International AG
    • 17.3.20. Lineage, Inc.
    • 17.3.21. Lonza Group Ltd.
    • 17.3.22. Movianto Group
    • 17.3.23. NextPharma Logistics GmbH
    • 17.3.24. Nippon Express Co., Ltd.
    • 17.3.25. Parexel International Corporation
    • 17.3.26. SEKO Logistics
    • 17.3.27. SF Express Co., Ltd.
    • 17.3.28. Thermo Fisher Scientific, Inc.
    • 17.3.29. United Parcel Service of America, Inc.
    • 17.3.30. YUSEN LOGISTICS CO., LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIO PHARMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHEMICAL PHARMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SPECIALIZED PHARMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE